Naratriptan

When ATH:
N02CC02

Pharmacological action.
Protivomigrenoznoe.

Application.

Migraine with aura and without aura (mild asthma), migraine status (in the complex therapy).

Contraindications.

Hypersensitivity, incl. to sulfonamides, hemiplegic or basilar migraine oftalmoplegicheskaya form, CHD, myocardial infarction, cerebrovascular accident, Peripheral Vascular Disease (syndrome, intermittent claudication), uncontrolled hypertension, pregnancy, youthful (to 18 years) and old age.

Side effects.

Paraesthesia, dizziness, drowsiness, weakness, sensation of pain, compression or contraction in the throat and neck, coronary vasospasm, peripheral circulatory disorders, nausea, vomiting.

Cooperation.

Do effect sedatives. Ergotamine and other protivomigrenoznye drugs increase the likelihood of adverse events.

Dosing and Administration.

Inside, during an attack, single 2,5 mg. При возобновлении симптомов мигрени — повторно не ранее чем через 4 no. The maximum daily dose - 5 mg. Для профилактики менструальной мигрени — 2,5 mg 1 once a day for several days, during or before the onset of menstruation.

Precautions.

У пациентов с почечной и печеночной недостаточностью суточная доза не должна превышать 2,5 mg. Не рекомендуется назначать при Cl креатинина менее 15 мл/мин и использовать для профилактики мигрени (except catamenial). Не следует применять в течение 24 ч после использования других триптанов или эрготамина и подобных ему препаратов. During the period of treatment should refrain from driving motor transport and work with potentially dangerous machinery, require attention and speed of reaction.